Your browser doesn't support javascript.
loading
Wearing-off symptoms during standard and extended natalizumab dosing intervals: Experiences from the COVID-19 pandemic.
Bringeland, Gerd Haga; Blaser, Nello; Myhr, Kjell-Morten; Vedeler, Christian Alexander; Gavasso, Sonia.
Afiliación
  • Bringeland GH; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway. Electronic address: gerd.haga.bringeland@helse-bergen.no.
  • Blaser N; Department of Informatics, University of Bergen, Bergen, Norway; Center for Data Science, CEDAS, University of Bergen, Bergen, Norway.
  • Myhr KM; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Vedeler CA; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Gavasso S; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
J Neurol Sci ; 429: 117622, 2021 10 15.
Article en En | MEDLINE | ID: mdl-34474301
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucoencefalopatía Multifocal Progresiva / Esclerosis Múltiple Recurrente-Remitente / COVID-19 Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Neurol Sci Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucoencefalopatía Multifocal Progresiva / Esclerosis Múltiple Recurrente-Remitente / COVID-19 Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Neurol Sci Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos